Humacyte, Inc. (HUMA)

Last Closing Price: 1.30 (2025-12-04)

Return on Equity (Quarterly)

Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity

Humacyte, Inc. (HUMA) had Return on Equity of 368.55% for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$0.75M
$-17.51M
$0.26M
$0.49M
$25.14M
$-24.39M
$6.88M
$-17.51M
$-17.51M
$-17.51M
$-17.51M
$-17.51M
$-17.51M
$-24.39M
$-22.52M
158.31M
158.31M
$-0.11
$-0.11
Balance Sheet Financials
$41.35M
$19.86M
$50.16M
$91.51M
$25.58M
$27.16M
$70.68M
$96.26M
$-4.75M
$-4.75M
$-4.75M
158.84M
Cash Flow Statement Financials
$-78.92M
$-0.84M
$4.31M
$95.29M
$19.84M
$-75.45M
$7.28M
--
--
Fundamental Metrics & Ratios
1.62
--
--
1.21
-6.28
65.47%
-3239.04%
-3239.04%
--
-2325.36%
-2325.36%
$-79.76M
--
--
--
0.01
0.01
0.70
128.84
Return on Equity
368.55%
368.55%
-19.13%
-78.16%
$-0.03
$-0.50
$-0.50